The inside story of Eli Lilly's 18-day race to secure an $8 billion deal for a drugmaker that's pioneering a new treatment for cancer
This is a Business Insider Prime story. Click the link below to read it.
- Best yoga mats
- IndiGo to raise ₹4,000 crore through stake sale
- Supreme Court adjourns AGR case hearing to August 14
- ICICI Bank sets floor price for QIP at ₹351.36 per share — to decide on allotment on August 14
- McKinsey, Facebook, Amazon, Nokia — and some other companies looking for a product manager right now